Journal of Advanced Pharmaceutical Technology & Research (JAPTR) is an Official Publication of Society of Pharmaceutical Education & Research™. It is an international journal published Quarterly.
Journal of Advanced Pharmaceutical Technology & Research (JAPTR) is available in online and print version.
It is a peer reviewed journal aiming to communicate high quality original research work, reviews, short communications, case report, Ethics Forum, Education Forum and Letter to editor that contribute significantly to further the scientific knowledge related to the field of Pharmacy i.e. Pharmaceutics, Pharmacology, Pharmacognosy, Pharmaceutical Chemistry. Articles with timely interest and newer research concepts will be given more preference.
All articles published in this journal represent the opinion of the authors and not reflect the official policy of the Journal of Advanced Pharmaceutical Technology & Research (JAPTR).
All papers are subjected to peer-review.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data
The journal is indexed with, or included in, the following:
DOAJ, EMBASE/ Excerpta Medica, Emerging Sources Citation Index, Indian Science Abstracts, PubMed Central, Scimago Journal Ranking, SCOPUS, Web of Science
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
Scope of the journal
This Journal publishes original research work, reviews, short communications, case report, ethics forum, education forum and letter to editor that contribute significantly to further the scientific knowledge related to the field of Pharmacy i.e. Pharmaceutics, Pharmacology, Pharmacognosy, Pharmaceutical Chemistry.
Journal of Advanced Pharmaceutical Technology & Research (JAPTR) hopes that researchers, research scholars, academicians, industrialists etc. would make use of this journal publication for the development in the field of Pharmaceutical science and advanced technology related to Pharmacy profession.
Medknow, part of Wolters Kluwer Health, is one of the largest open access publishers worldwide with more than 450+ medical journals in its portfolio. Students, researchers, clinicians and other healthcare professionals worldwide access Medknow journals to help them fuel new discoveries and improve patient care.
Founded in 1997, Medknow is a well-respected medical publisher that fully supports many of the popular open access models through its peer-review management system. Medknow’s open access policy has resulted in more than a half a million article downloads monthly for all of its journals.
Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Lippincott Williams & Wilkins, Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource®, Lexicomp® and ProVation® Medical. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with annual revenues (2019) of €3.4 billion ($4.7 billion), approximately 19,000 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.
Online and Print Scholarly Publishing, Peer-Review System, Specialized in Medical Research, Largest Open Access Publisher